(Q35573313)

8 August 2017

title

Gene expression profiling: will it complement or replace immunophenotyping? (English)

1 reference

8 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14592648

gene expression profiling

27 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14592648

27 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1521-6926(03)00069-0

27 March 2024

author name string

Adolfo A. Ferrando

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14592648

27 March 2024

A. Thomas Look

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14592648

27 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14592648

27 March 2024

publication date

1 December 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S1521692603000690?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S1521-6926(03)00069-0

https://api.elsevier.com/content/article/PII:S1521692603000690?httpAccept=text/plain

27 March 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/S1521-6926(03)00069-0

Best Practice and Research: Clinical Haematology

27 March 2024

published in

1 reference

8 August 2017

volume

16

1 reference

8 August 2017

issue

4

1 reference

8 August 2017

page(s)

645-652

1 reference

Amplified RNA synthesized from limited quantities of heterogeneous cDNA.

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900069-0

7 January 2021

High-fidelity mRNA amplification for gene profiling.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900069-0

7 January 2021

Quantitative analysis of mRNA amplification by in vitro transcription.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900069-0

7 January 2021

Probe generation directly from small numbers of cells for DNA microarray studies

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900069-0

7 January 2021

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900069-0

7 January 2021

Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900069-0

7 January 2021

MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900069-0

7 January 2021

Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900069-0

7 January 2021

Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900069-0

7 January 2021

Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: a gene-expression study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900069-0

7 January 2021

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900069-0

7 January 2021

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900069-0

7 January 2021

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900069-0

7 January 2021

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900069-0

7 January 2021

Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900069-0

7 January 2021

Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900069-0

7 January 2021

Identifiers

DOI

1 reference

8 August 2017

1 reference